You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《半日總結》恆指跌334點 網易挫6% 信義系受壓
美股道指上週五(17日)跌532點或近1.5%,港股今早低開後跌幅加劇,恆指跌穿二萬三關,一度挫350點曾低見22,842點,中午收報22,858點,跌334點或1.4%;國指跌119點或1.5%,報8,098點;恆生科技指數跌137點或2.4%,報5,543點。大市半日成交總額636.19億元。滬、深港通南下交易半日分別淨流入14.68億及10.72億元。 金融股匯控(00005.HK)跌1.4%報45.75元。友邦(01299.HK)跌1.2%報78.7元。建行(00939.HK)跌0.2%。中移動(00941.HK)首次公開發行A股明日(21日)網上路演,另外公司11月5G上客量放緩,今日半日股價跌0.3%。港交所(00388.HK)跌1.9%。 科技股騰訊(00700.HK)跌1.6%報431.2元。阿裏巴巴(09988.HK)跌0.8%報116.1元。小米(01810.HK)跌2.5%。美團(03690.HK)跌1.8%。網易(09999.HK)挫6.2%報144元。京東(09618.HK)跌3.9%。 永利澳門(01128.HK)月內結束與博彩中介公司合作,股價升1.3%。其他賭股金沙(01928.HK)則跌0.4%。澳博(00880.HK)及美高梅中國(02282.HK)跌近2%。 佳兆業(01638.HK)逾117億美元優先票據未償還及商全面債務重組,該股復牌挫14.1%。標普降中國恆大(03333.HK)評級至選擇性違約,恆大半日跌4.9%。碧桂園(02007.HK)跌2.4%。 信義玻璃(00868.HK)半日跌7.3%報17.52元,爲表現最差藍籌股,同系信義光能(00968.HK)跌5.2%。藥明生物(02269.HK)跌5.8%。體品股安踏(02020.HK)及李寧(02331.HK)分別挫4.8%及4.1%。比亞迪(01211.HK)亦跌4.7%。 華人置業(00127)私有化計劃遭否決,股價曾瀉逾35%一度低見2.45元,半日收報2.68元跌29.1%。 中基長壽科學(00767.HK)曾挫63.4%一度低見0.086元,半日跌48.5%見0.121元,公司遭聯交所指未有足夠業務運作保證股份續上市。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account